Chinese
Home
About Livzon
Milestones
Leaders' Caring
Company Honors
Cultural Vision
Contact Us
Media
Livzon News
Employment system
Investor Relations
Company Governance
Announcement
Financial Reports
ESG Report
Shareholder Returns
Stock Information
Sustainable Development
Human Development
Board Diversity Policy
Business Ethics
Supplier
Environment, Occupational Health and Safety (EHS)
Philanthropy
Privacy Policy
Tax policy
ESG Ratings and Honors
Product
Leading Products
Products List
ADR Reporting
R&D
R&D Platforms
Livzon microspheres
Livzon Bio
Livzon Research Institute
R&D Achievements
IP Achievements
Overseas Market
Overseas Business
Specialty Products
Certificates
Contact us
Join Us
Social Recruitment
Campus Recruitment
Compensation and Benefits
Appeal Against
Bidding procurement
Tender Announcement
Supplier Login
Supervision and Reporting
Contact information
Online message
ESG report
Shareholder returns
Stock information
Contacts
Dividend for the Third Quarter Ended 30 September 2026 (updated)
File size:
42.8KB
File Type:
pdf
2026-11-13
2026-11-12
POSITIONS HELD BY CURRENT DIRECTORS AT THE BOARD AND THE BOARD COMMITTEES
153.2KB
(1) POLL RESULTS OF THE 2026 SECOND EXTRAORDINARY GENERAL MEETING HELD ON 12 NOVEMBER 2026; (2) APPOINTMENT OF A NON-EXECUTIVE DIRECTOR; AND (3) DIVIDEND FOR THE THIRD QUARTER ENDED 30 SEPTEMBER 2026
208.9KB
CONNECTED TRANSACTION ACQUISITION OF SHARES IN XINBEIJIANG PHARMA
263.4KB
2026-11-11
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2026
67.6KB
2026-11-02
VOLUNTARY ANNOUNCEMENT OBTAINMENT OF THE DRUG REGISTRATION CERTIFICATE FOR WANDAI TANG GRANULES
218.4KB
2026-10-27
VOLUNTARY ANNOUNCEMENT OBTAINMENT OF THE DRUG CLINICAL TRIAL APPROVAL NOTICE FOR TIANGE DINGXUAN GRANULES
190.0KB
VOLUNTARY ANNOUNCEMENT OBTAINMENT OF THE DRUG CLINICAL TRIAL APPROVAL NOTICE FOR RECOMBINANT HUMANIZED ANTI-FXI BISPECIFIC ANTIBODY INJECTION
188.3KB
Dividend for the Third Quarter Ended 30 September 2026
496.4KB
2026-10-23
